Clin-Alert
Select your subscription type:
To purchase this journal subscription or a back issue please contact our customer services team with details of the journal, volume or issue you would like.
Useful information for subscribing to our journals, including pricing, institutional and consortia subscriptions, information for agents and more.
View Pricing And Subscription InformationDescription
This valuable newsletter provides pharmacists, physicians, and other health care professionals with comprehensive summaries of adverse drug reactions, drug interactions, and market withdrawals from over 100 key medical and research journals from around the world. CLIN-ALERT’s primary focus is drug-drug interactions, but it also explores food-drug interactions, medication errors and dietary supplements.
Reports include:
- The primary drug suspected, (including common trade names, dosages, and duration of therapy)
- The adverse drug reaction/interaction
- Relevant laboratory data
- Management of the reaction
- Any relevant pre-existing condition
- Potential legal repercussions
- Complete journal citation including reprint information.
CLIN-ALERT also features First Report—notice of the first documented report of an adverse clinical event.
This journal is a member of the Committee on Publication Ethics (COPE).
Description
This valuable newsletter provides pharmacists, physicians, and other health care professionals with comprehensive summaries of adverse drug reactions, drug interactions, and market withdrawals from over 100 key medical and research journals from around the world. CLIN-ALERT’s primary focus is drug-drug interactions, but it also explores food-drug interactions, medication errors and dietary supplements.
Reports include:
- The primary drug suspected, (including common trade names, dosages, and duration of therapy)
- The adverse drug reaction/interaction
- Relevant laboratory data
- Management of the reaction
- Any relevant pre-existing condition
- Potential legal repercussions
- Complete journal citation including reprint information.
CLIN-ALERT also features First Report—notice of the first documented report of an adverse clinical event.
This journal is a member of the Committee on Publication Ethics (COPE).
Current Volume: 64 | Current Issue: 9-10 | ISSN: 00694770 | ESSN: 1530812X | Frequency: 24 Times Year | Submission Guidelines | Get Email Alerts
| Subscription Type | Format | Price |
|---|---|---|
| Individual rates | Individual, Single Print Issue | $11.00 |
| Individual rates | Individual Subscription, Print Only | $198.00 |
This valuable newsletter provides pharmacists, physicians, and other health care professionals with comprehensive summaries of adverse drug reactions, drug interactions, and market withdrawals from over 100 key medical and research journals from around the world. CLIN-ALERT’s primary focus is drug-drug interactions, but it also explores food-drug interactions, medication errors and dietary supplements.
Reports include:
- The primary drug suspected, (including common trade names, dosages, and duration of therapy)
- The adverse drug reaction/interaction
- Relevant laboratory data
- Management of the reaction
- Any relevant pre-existing condition
- Potential legal repercussions
- Complete journal citation including reprint information.
CLIN-ALERT also features First Report—notice of the first documented report of an adverse clinical event.
This journal is a member of the Committee on Publication Ethics (COPE).